Literature DB >> 21629671

Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.

Susan Wilson1, Dieter Brömme.   

Abstract

Cathepsin K, a papain-like cysteine protease, is highly expressed in osteoclasts and plays a critical role in bone resorption. Dysfunction of the enzyme leads to various skeletal abnormalities. The recent knowledge that the collagenolytic activity of cathepsin K depends on interactions with bone and cartilage-resident glycosaminoglycans (GAGs) may shed some light on diseases such as mucopolysaccharidoses (MPSs). MPSs are a group of lysosomal storage diseases characterized by the accumulation of GAGs in tissues including bone. Typical pathological features of these diseases include skeletal abnormalities such as dysostosis multiplex, short stature, and multiple irregularities in bone development. We describe how further investigation of the cathepsin K/GAG complexes could provide valuable insights into the bone pathology associated with MPS diseases. In this review, we discuss the inhibition of osteoclast function through altered activity of cathepsin K by GAGs and offer insight into a mechanism for the bone pathology seen in MPS patients.

Entities:  

Keywords:  Cathepsin K; cartilage; chondroitin sulfate; collagen; glycosaminoglycan; mucopolysaccharidoses; osteoclast

Year:  2010        PMID: 21629671      PMCID: PMC3103771          DOI: 10.3233/PRM-2010-0116

Source DB:  PubMed          Journal:  J Pediatr Rehabil Med        ISSN: 1874-5393


  50 in total

1.  Mechanism of shortened bones in mucopolysaccharidosis VII.

Authors:  Jason A Metcalf; Yanming Zhang; Matthew J Hilton; Fanxin Long; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-03-25       Impact factor: 4.797

Review 2.  Vesicular trafficking in osteoclasts.

Authors:  Fraser P Coxon; Adam Taylor
Journal:  Semin Cell Dev Biol       Date:  2008-08-14       Impact factor: 7.727

3.  Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.

Authors:  S Théoleyre; S Kwan Tat; P Vusio; F Blanchard; J Gallagher; S Ricard-Blum; Y Fortun; M Padrines; F Rédini; D Heymann
Journal:  Biochem Biophys Res Commun       Date:  2006-06-30       Impact factor: 3.575

4.  Arthroscopic and histologic findings in Morquio's syndrome.

Authors:  Thomas Kalteis; Thomas Schubert; Wolfgang Christopher Caro; Josef Schröder; Christian Lüring; Joachim Grifka
Journal:  Arthroscopy       Date:  2005-02       Impact factor: 4.772

5.  Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

Authors:  B D Gelb; G P Shi; H A Chapman; R J Desnick
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

Review 6.  The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.

Authors:  Yoshiyuki Yasuda; Jadwiga Kaleta; Dieter Brömme
Journal:  Adv Drug Deliv Rev       Date:  2005-04-15       Impact factor: 15.470

7.  Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.

Authors:  Eun-Ju Chang; Hyon Jong Kim; Jeongim Ha; Hyung Joon Kim; Jiyoon Ryu; Kwang-Hyun Park; Uh-Hyun Kim; Zang Hee Lee; Hyun-Man Kim; David E Fisher; Hong-Hee Kim
Journal:  J Cell Sci       Date:  2006-12-12       Impact factor: 5.285

8.  Hurler syndrome with special reference to histologic abnormalities of the growth plate.

Authors:  C P Silveri; F S Kaplan; M D Fallon; E Bayever; C S August
Journal:  Clin Orthop Relat Res       Date:  1991-08       Impact factor: 4.176

Review 9.  Cathepsin K inhibitors as treatment of bone metastasis.

Authors:  Céline Le Gall; Edith Bonnelye; Philippe Clézardin
Journal:  Curr Opin Support Palliat Care       Date:  2008-09       Impact factor: 2.302

10.  Regulation of collagenase activities of human cathepsins by glycosaminoglycans.

Authors:  Zhenqiang Li; Yoshiyuki Yasuda; Weijie Li; Matthew Bogyo; Norman Katz; Ronald E Gordon; Gregg B Fields; Dieter Brömme
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

View more
  5 in total

1.  Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.

Authors:  Mona Schmidt; Sandra Breyer; Ulrike Löbel; Sinef Yarar; Ralf Stücker; Kurt Ullrich; Ingo Müller; Nicole Muschol
Journal:  Orphanet J Rare Dis       Date:  2016-07-08       Impact factor: 4.123

2.  TGF-ß Regulates Cathepsin Activation during Normal and Pathogenic Development.

Authors:  Heather Flanagan-Steet; Courtney Christian; Po-Nien Lu; Megan Aarnio-Peterson; Laura Sanman; Stephanie Archer-Hartmann; Parastoo Azadi; Matthew Bogyo; Richard A Steet
Journal:  Cell Rep       Date:  2018-03-13       Impact factor: 9.423

Review 3.  Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.

Authors:  Valeria De Pasquale; Anna Moles; Luigi Michele Pavone
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

4.  Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients.

Authors:  Camelia Alkhzouz; Georgiana Cabau; Cecilia Lazea; Carmen Asavoaie; Simona Bucerzan; Andreea Manuela Mirea; Marius Farcas; Maria Miclaus Jnr; Radu Popp; Diana Miclea
Journal:  Pharmgenomics Pers Med       Date:  2021-03-17

5.  Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry.

Authors:  Lynda E Polgreen; Luisa Bay; Lorne A Clarke; Nathalie Guffon; Simon A Jones; Joseph Muenzer; Ana Lorena Flores; Kathryn Wilson; David Viskochil
Journal:  Am J Med Genet A       Date:  2022-07-23       Impact factor: 2.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.